Physical Organic Chemistry: Opportunities in Synthesis, Materials and Pharmaceuticals

该申请旨在催化和维持英国在物理有机化学研究能力的新维度。我们在物理有机化学方面的战略联盟将提供独特的专业知识，以解决材料化学，合成方法和药物发现和开发等领域的研究机会。它将有能力解决从固态到溶液和气相，从小分子到生物聚合物，从纳米级到中试工厂的问题。我们专注于对全球工业和学术化学具有国际意义的主题，这将有助于（i）推动21世纪电子材料的创造，设备和技术（ii）了解和利用协助化学反应的方法，有可能彻底改变化学和制药工业的能源使用（iii）通过了解药物系统中的分子识别，包括药物-受体、药物-药物和药物-载体复合物，提供新的和更有效的药物。化学品和制药工业各部门迄今提供的初步实质性支助突出了这一进程的重要性。它最初将导致26个新的任命，我们期待着随着该计划的展开更有活力的增长。

This application aims to catalyse and sustain a new dimension in UK research capability in physical organic chemistry. Our strategic alliance in physical organic chemistry will provide a unique continuum of expertise to tackle research opportunities in areas as diverse as materials chemistry, synthesis methodologies and pharmaceutical discovery and development. It will have the capability to address issues from solid-state to solution and gas-phase, from small molecules to biopolymers, and from nanoscale to pilot plant. We focus on topics of international significance to industry worldwide as well as to academic chemistry, that will help to (i) drive the creation of 21st-century electronic materials, devices and technologies (ii) understand and exploit methodologies for assisting chemical reactions with the potential to revolutionise energy use in chemicals and pharmaceuticals industries (iii) provide new and more effective medicines through understanding molecular recognition in pharmaceutical systems including drug-receptor, drug-drug and drug-carrier complexes. Its importance is underlined by the initial substantial support from diverse sectors of the chemicals and pharmaceuticals industry that we have so far put in place. It will initially lead to 26 new appointments, and we look forward to even more dynamic growth as the program unfolds.